2-benzyl-8-(3-phenyl-1,2,4-oxadiazol-5-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one结构式
|
常用名 | 2-benzyl-8-(3-phenyl-1,2,4-oxadiazol-5-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one | 英文名 | 2-benzyl-8-(3-phenyl-1,2,4-oxadiazol-5-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one |
|---|---|---|---|---|
| CAS号 | 1190021-31-8 | 分子量 | 369.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H15N5O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-benzyl-8-(3-phenyl-1,2,4-oxadiazol-5-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one |
|---|
| 分子式 | C21H15N5O2 |
|---|---|
| 分子量 | 369.4 |
| InChIKey | BBPKMPUSAIOHKE-UHFFFAOYSA-N |
| SMILES | O=c1n(Cc2ccccc2)nc2c(-c3nc(-c4ccccc4)no3)cccn12 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|